Thursday, May 27, 2021 2:07:28 PM
IMO, #1 is that we are at the waiting stage for possible directions of where Ifenprodil takes us.*
#2>>>A defined second main path of Stroke/DMT-MoU from those (TOUGH) decisions by management, the QUICK work by the New CSO Team, AND They have ALREADY produce these LEGAL Thingees that has enabled AGN grab an important section of this possible market. JMHO.
C.M apparently had the Crews working OT...GLTA...
"Algernon has also filed new provisional patents for new forms of DMT, in addition to formulation, dosage and method of use claims for ischemic stroke. The Company has also filed claims for combination therapy of DMT and Constraint Induced Movement Therapy (“CIMT”)."
*Otherwise it's Ben Dover cheep PP time..
FEATURED Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • May 16, 2024 8:13 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM
HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM
Integrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share • INTV • May 15, 2024 10:30 AM
Swifty Global Announces Impressive Financial Results for Q1 2024 • DRCR • May 15, 2024 10:25 AM